Boditech Med Inc. (KOSDAQ:206640)
South Korea
· Delayed Price · Currency is KRW 11,340
-760 (-6.28%)
At close: Mar 9, 2026
Boditech Med Revenue
Boditech Med had revenue of 39.95B KRW in the quarter ending September 30, 2025, with 6.26% growth. This brings the company's revenue in the last twelve months to 151.75B, up 6.97% year-over-year. In the year 2024, Boditech Med had annual revenue of 138.16B with 2.94% growth.
Revenue (ttm)
151.75B
Revenue Growth
+6.97%
P/S Ratio
1.63
Revenue / Employee
280.50M
Employees
541
Market Cap
247.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 138.16B | 3.94B | 2.94% |
| Dec 31, 2023 | 134.22B | 16.14B | 13.67% |
| Dec 31, 2022 | 118.08B | -39.63B | -25.13% |
| Dec 31, 2021 | 157.71B | 13.58B | 9.42% |
| Dec 31, 2020 | 144.13B | 71.33B | 97.99% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CMG Pharmaceutical | 100.41B |
| JW Holdings | 935.51B |
| Hyundai Pharmaceutical | 108.14B |
| BNC Korea | 98.11B |
| Suheung | 704.47B |
| Korea United Pharm | 161.44B |
| Ilyang Pharmaceutical Co.,Ltd | 276.09B |
| Chong Kun Dang Holdings | 950.10B |